Department of Infectious Diseases, 119754Konkuk University Medical Center, Konkuk University School of Medicine, Seoul, Republic of Korea.
Department of Infectious Diseases, 65526Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
J Intensive Care Med. 2021 Sep;36(9):1053-1060. doi: 10.1177/0885066620985538. Epub 2020 Dec 30.
Bloodstream infection (BSI) is an important complication of extracorporeal membranous oxygenation (ECMO) and a major cause of mortality. This study evaluated the epidemiological and clinical characteristics of BSI that occur during ECMO application according to microbial etiology.
Adult patients who underwent ECMO from January 2009 to December 2016 were retrospectively analyzed for BSI episodes at a 2,700-bed, tertiary center. Epidemiological and clinical characteristics and outcomes of BSI were evaluated and were compared for etiologic groups (gram-positive cocci, gram-negative rods, and fungi groups). Risk factors for 14-day mortality were analyzed.
A total of 1,100 patients underwent ECMO during the study period, and 65 BSI episodes occurred in 61 patients. The BSI incidence was 8.3 episodes/1,000 ECMO days, which significantly decreased over time ( = 0.03), primarily in gram-positive cocci BSI. Gram-positive cocci, gram-negative rods, and fungi accounted for 38%, 40%, and 22% of the 73 blood isolates, respectively. Baseline characteristics were comparable between groups. Catheter-related infection (CRI) and pneumonia were the most common sources of BSI; 52% of gram-positive cocci BSIs and 79% of fungi BSIs were caused by CRI, and 75% of gram-negative BSIs by pneumonia. Patients with gram-negative rods BSI died more frequently and earlier than those with other BSIs. Independent risk factors for 14-day mortality were older age and gram-negative rods BSI.
The decreased BSI incidence during ECMO was mainly because of the decrease of gram-positive cocci BSI. The high early mortality of gram-negative rods BSI makes prevention and adequate treatment necessary.
血流感染(BSI)是体外膜肺氧合(ECMO)的重要并发症,也是导致死亡率的主要原因。本研究根据微生物病因评估 ECMO 应用期间发生的 BSI 的流行病学和临床特征。
回顾性分析 2009 年 1 月至 2016 年 12 月在一家拥有 2700 张床位的三级中心接受 ECMO 的成人患者的 BSI 发作。评估 BSI 的流行病学和临床特征及结局,并按病原体组(革兰阳性球菌、革兰阴性杆菌和真菌组)进行比较。分析 14 天死亡率的危险因素。
研究期间共有 1100 例患者接受 ECMO,61 例患者发生 65 例 BSI。BSI 发生率为 8.3 例/1000 ECMO 天,且随时间推移呈显著下降趋势(=0.03),主要是由于革兰阳性球菌 BSI 的减少。革兰阳性球菌、革兰阴性杆菌和真菌分别占 73 株血培养分离株的 38%、40%和 22%。各组间的基线特征无差异。导管相关感染(CRI)和肺炎是 BSI 的最常见来源;52%的革兰阳性球菌 BSI 和 79%的真菌 BSI 由 CRI 引起,75%的革兰阴性杆菌 BSI 由肺炎引起。革兰阴性杆菌 BSI 的患者死亡更早且更频繁。14 天死亡率的独立危险因素为年龄较大和革兰阴性杆菌 BSI。
ECMO 期间 BSI 发生率的下降主要是由于革兰阳性球菌 BSI 的减少。革兰阴性杆菌 BSI 的早期高死亡率使得预防和充分治疗变得必要。